印度对帕金森病的残疾证明:挑战和前进的道路
M Arun1, Priya Treesa Thomas1, Nitish L Kamble2
1Department of Psychiatric Social Work, NIMHANS, Bengaluru, Karnataka, India.
概括
印度帕金森病患者需要具备残疾证明才能获得福利. 简化这一过程对于确保符合条件的个人获得必要支持至关重要.
科学领域:
- 神经学 神经学
- 公共卫生政策 公共卫生政策
背景情况:
- 帕金森病 (PD) 是一种复杂的神经退行性疾病.
- 在印度,获得政府计划和福利需要PD患者的强制性残疾认证.
研究的目的:
- 突出印度为帕金森病患者简化残疾认证程序的必要性.
- 倡导改善帕金森病患者获得福利的机会.
主要方法:
- 对印度目前帕金森病残疾认证程序的分析.
- 审查患者在获得认证时面临的挑战.
主要成果:
- 现有的残疾认证程序对于患有帕金森病的人来说是繁的.
- 认证过程中的障碍阻碍了获得基本计划和福利的机会.
结论:
- 印度对帕金森病的残疾认证过程需要大幅简化和精简.
- 一个精简的流程将确保所有符合条件的帕金森病患者平等获得福利.
相关概念视频
01:24Parkinson's Disease: Treatment
278
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
278
01:15Parkinson's Disease: Overview
560
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
560